Cash and Cash Equivalents, at Carrying Value of Renalytix plc from 30 Jun 2018 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Renalytix plc quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 30 Jun 2018 to 30 Sep 2024.
  • Renalytix plc Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Sep 2024 was $909,000, a 93% decline year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Renalytix plc Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $909,000 -$12,982,000 -93% 30 Sep 2024 10-Q 19 Nov 2024 2025 Q1
Q2 2024 $4,680,000 -$20,002,000 -81% 30 Jun 2024 10-Q 19 Nov 2024 2025 Q1
Q1 2024 $4,704,000 -$28,323,000 -86% 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 $5,619,000 -$18,197,000 -76% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 $13,891,000 -$17,149,000 -55% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 $24,682,000 -$16,651,000 -40% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q1 2023 $33,027,000 +$666,000 +2.1% 31 Mar 2023 6-K 09 Jun 2023
Q4 2022 $23,816,000 -$16,112,000 -40% 31 Dec 2022 6-K 30 Mar 2023
Q3 2022 $31,040,000 30 Sep 2022 6-K 30 Nov 2022
Q2 2022 $41,333,000 -$23,795,000 -37% 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q1 2022 $32,361,000 31 Mar 2022 6-K 30 Jun 2022
Q4 2021 $39,928,000 31 Dec 2021 6-K/A 29 Apr 2022
Q2 2021 $65,128,000 +$51,835,000 +390% 30 Jun 2021 20-F 31 Oct 2022 2022 FY
Q2 2020 $13,293,000 +$5,092,000 +62% 30 Jun 2020 20-F/A 01 Aug 2022 2021 FY
Q2 2019 $8,201,000 +$8,119,000 +9901% 30 Jun 2019 20-F/A 01 Aug 2022 2021 FY
Q2 2018 $82,000 30 Jun 2018 20-F 21 Oct 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.